Abstract
Background
Craniopharyngioma accounts for 5–10% of childhood tumors and, despite of the benign histological features, its clinical course can be malignant because of critical anatomical relationships with neural and vascular structures and the possible morbidity associated to resection. Only a few studies have addressed the molecular characterization of the cyst fluid so far and the mechanisms of action of intracystic agents are not clearly understood yet.
Methods
The acidic soluble proteins contained in the cystic fluid of six patients with cystic craniopharyngioma, three of them treated with intratumoral interferon-α, were analyzed. A high performance liquid chromatography electrospray ionization mass spectrometry analysis was performed.
Findings
The antimicrobial peptides α-defensins 1–3 relevant for innate immunity were detected in the cystic fluid before the intratumoral treatment. Amount of peptides significantly decreased in cystic fluid during pharmacological treatment.
Interpretation
Detection of α-defensins 1–3 excludes that cyst fluid formation can derive from disruption of blood–brain barrier and suggests the involvement of innate immune response in pathology of craniopharyngioma cyst formation. The reduction of α-defensins could derive both from direct antitumoral effect of interferon-α on squamous epithelial cells of craniopharyngioma cyst and from its immuno-modulatory effects on the recruitment of cells of innate immune systems. Interestingly, the clinical patient outcome well correlates with the gradual reduction of α-defensins 1–3 amount. Additional studies will be necessary to establish the role of these molecules in the pathogenesis of craniopharyngioma, and further investigations will be necessary to confirm the efficacy of the antitumoral activity of interferon-α.
Similar content being viewed by others
References
Alen JF, Boto GR, Lagares A, de la Lama A, Gomez PA, Lobato RD (2002) Intratumoral bleomycin as a treatment for recurrent cystic craniopharyngioma. Case report and review of the literature. Neurocirurgia (Astur) 13:479–485
Arefyeva IA, Semenova JB, Zubairaev MS, Kondrasheva EA, Moshkin AV (2002) Analysis of fluid in craniopharyngioma-related cysts in children: proteins, lactate and pH. Acta Neurochir 144:551–554
Càceres A (2005) Intracavitary therapeutic options in the management of cystic craniopharyngioma. Child’s Nerv Syst 21:705–718
Cavalheiro S, Dastoli PA, Silva NS, Toledo S, Lederman H, da Silva MC (2005) Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma. Child’s Nerv Syst 21:719–724
Di Rocco C, Massimi L, Tamburrini G, Pettorini BL, Novegno F, Sturiale C, Paternoster G, Caldarelli M (2007) Management of cystic craniopharyngiomas with intra-tumoural INF-a administration: clinical results and surgical techniques. Child’s Nerv Syst 23:1073
Ferrantini M, Capone I, Belardelli F (2007) Interferon-α and cancer: mechanisms of action and new perspectives of clinical use. Biochimie 89:884–893
Ganz T, Selsted ME, Lehrer RI (1990) Defensins. Eur J Haematol 44:1–8
Ganz T, Lehrer RI (1995) Defensins. Pharmac Ther 66:191–205
Garrè ML, Cama A (2007) Craniopharyngioma: modern concepts in pathogenesis and treatment. Curr Opin Pediatr 19:471–479
Hirano A, Ghatek NR, Zimmerman HM (1973) Fenestrated blood vessels in craniopharyngioma. Acta Neuropathol 26:171–177
Honegger J, Rennae C, Fahlbusch R, Adams EF (1997) Progesteron receptor gene expression in craniopharyngiomas and evidence for biological activity. Neurosurgery 41:1359–1364
Ierardi DF, Fernandes MJS, Silva IR, Thomazini-Gouveia J, Silva NS, Dastoli P, Toledo SRC, Cavalheiro S (2007) Apoptosis in alpha interferon (IFN-α) intratumoral chemotherapy for cystic craniopharyngiomas. Child’s Nerv Syst 23:1041–1046
Kalapurakal JA, Goldman S, Hsieh YC, Tomita T, Marymont MH (2003) Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med Pediatr Oncol 40:214–218
Kamal R, Jindal A, Suri A, Mahapatra AK (1999) Effect of craniopharyngioma fluid on femoral vessels of rat. Neurol Res 21:796–798
Lingen MW, Polverini PJ, Bouck NP (1998) Retinoic acid and interferon alpha act sinergistically as antiangiogenic and antitumor agents against human head and neck squamous cell carcinoma. Cancer Res 58:5551–5558
Lundy FT, Orr DF, Gallagher JR, Maxwell P, Shaw C, Napier SS, Cowan CG, Lamey PJ, Marley JJ (2004) Identification and overexpression of human neutrophil α-defensins (human neutrophil peptides 1, 2 and 3) in squamous cell carcinomas of the human tongue. Oral Oncol 40:139–144
Mayhew TM, Olsen DR (1991) Magnetic resonance imaging (MRI) and model-free estimates of brain volume determined using the Cavalieri principle. J Anat 178:133–144
Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson SJ, Wilson MW, Lustig RH, Kun LE (2002) Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001. Int J Radiat Oncol Biol Phys 53:533–542
Mizukawa N, Sugiyama K, Ueno T, Mishima K, Takagi S, Sugahara T (2000) Detection of human α-defensin-1, an antimicrobial peptide, in the fluid of jaw cysts. Oral Surg Oral Med Oral Path 90:78–81
Mori S, Yamaguchi K, Morita H, Mohri N (1985) Distribution of HNK-1+ cells in malignant lymphomas. Acta Pathol Jpn 35:339–350
Panyutich AV, Panyutich EA, Krapivin VA, Baturevichet EA, Ganz T (1993) Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med 122:202–207
Petito CK, De Girolamo U, Earle KM (1976) Craniopharyngiomas. A clinical and pathological review. Cancer 37:1944–1952
Pisano E, Cabras T, Montaldo C, Piras V, Inzitari R, Olmi C, Castagnola M, Messana I (2005) Peptides of human gingival crevicular fluid determined by HPLC-ESI-MS. J Oral Sci 113:462–468
Satoh H, Uozumi T, Arita K, Kurisu K, Hotta T, Kiya K, Ikawa F, Goishi J, Sogabe T (1993) Spontaneous rupture of craniopharyngioma cysts. A report of 5 cases and review of the literature. Surg Neurol 40:414–419
Stevens A, Kloter I, Roggendorf W (1988) Inflammatory infiltrates and natural killer cell presence in human brain tumors. Cancer 61:738–743
Strander H (1986) Interferon treatment of human neoplasia. Adv Cancer Res 46:1–26
Szeifert GT, Julow J, Szabolcs M, Slowik F, Balint K, Pasztor E (1991) Secretory component of cystic craniopharyngiomas: a mucino-histochemical and electron-microscopic study. Surg Neurol 36:286–293
Vaquero J, Zurita M, de Oya S, Coca S, Morales C, Salas C (1999) Expression of vascular permeability factor in craniopharyngioma. J Neurosurg 91:831–834
Vidal S, Kovacs K, Lloyd RV, Meyer FB, Scheithauer BW (2002) Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome. Cancer 94:738–745
Zhang Z, Marshall GA (1998) A universal algorithm for fast and automated charge state deconvolution of electrospray mass-to-charge ratio spectra. J Am Soc Mass Spectrom 9:225–233
Conflicts of interest
The authors declare they have no financial and personal interests in the material discussed in the present paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pettorini, B.L., Inzitari, R., Massimi, L. et al. The role of inflammation in the genesis of the cystic component of craniopharyngiomas. Childs Nerv Syst 26, 1779–1784 (2010). https://doi.org/10.1007/s00381-010-1245-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-010-1245-4